373.30EUR-0.76%Mkt Cap: 218.76B $P/E: 26.791d ago
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthriti…
Industry Peers
Drug Manufacturers - General$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$238.75BUSDP/E 27.4
$190.75BUSDP/E 11.3
$183.02BUSD
$160.96BUSDP/E 37.2
$138.11BUSDP/E 14.9
$101.30BUSDP/E 24.0
$98.67BUSDP/E 16.3
$51.91BUSD
$32.74BUSDP/E 39.4
MRV
Marvell Technology, Inc.$26.57BUSDP/E 10.1
$12.10BUSDP/E 18.9
Key Statistics
Company
Market Cap218.76B $
Enterprise Value261.89B $
Revenue (TTM)41.41B $
Gross Profit26.86B $
Net Income (TTM)8.38B $
Revenue/Share76.82 USD
Last Price373.30 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees31.5K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS0311621009
Valuation
P/E (Trailing)26.79
P/E (Forward)—
PEG2.16
EV/EBITDA13.95
EV/Revenue6.32
P/S5.19
P/B19.56
EPS (TTM)13.89
EPS (Forward)—
52W Range
361.9562% of range380.30
52W High380.30 EUR
52W Low361.95 EUR
Profitability
Gross Margin67.25%
Oper. Margin35.55%
EBITDA Margin45.33%
Profit Margin20.98%
ROE89.06%
ROA8.51%
Growth
Revenue Growth9.50%
Earnings Growth64.90%
Cash Flow & Leverage
Operating CF10.82B $
CapEx (TTM)2.02B $
FCF Margin22.69%
FCF Yield4.30%
Net Debt47.08B $
Net Debt/EBITDA2.51
Balance Sheet
Debt/Equity6.31
Current Ratio1.37
Quick Ratio0.95
Book Value/Sh18.69 EUR
Cash/Share25.88 EUR
Dividends
Fwd Div Rate8.790 EUR
Trail. Div Rate9.800 EUR
Div. Yield2.44%
5Y Avg Yield3.06%
Payout Ratio60.87%
Ex-Div DateAug 21, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.541.00M
Float539.16M
Insiders0.22%
Institutions85.23%
Technical
SMA 50324.01 (+15.2%)
SMA 200302.52 (+23.4%)
Beta0.41
S&P 52W Chg20.80%
Avg Vol (30d)456
Avg Vol (10d)754
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—